Post-covid-19 immune signatures: Antibody and Th1 cytokine profiles among healthcare workers in Côte d’Ivoire
The Egyptian journal of Immunology · 2026
DOI: 10.55133/eji.330107 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian journal of Immunology, 2026. Verfasst von Amah P V Goran-Kouacou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Allergology, Faculty of Medical Sciences, Université Félix Houphouët-Boigny, Abidjan, Côte d'Ivoire. Hauptthemen laut MEDLINE: COVID-19, Th1 Cells, Cytokines, Health Personnel.
Abstract (Originalsprache)
The post-SARS-CoV-2 immune response involves both neutralizing antibodies (NAbs) and T-cell cooperation. Healthcare workers, highly exposed in daily practice, represent a relevant population for study. This study aimed to describe the post-COVID-19 immune profiles of Ivorian healthcare workers by analyzing the association between antibodies (IgM, IgG, NAbs) and Th1 cytokines (IL-2, IFN-, TNF-α). This cross-sectional study, conducted during January 2022 to June 2023 in three university hospitals in Abidjan, included 36 participants with RT-PCR-confirmed infection. IgM and IgG were measured using an automated analyzer. NAbs were quantified on a multiparametric test system. IL-2, IFN-, and TNF-α were measured by a flow cytometer. A robust profile was defined by the combined presence of IgG ≥ 250 Binding Antibody Units (BAU)/ml, NAbs ≥ 800 BAU/ml, and at least one Th1 cytokine (IL-2 ≥ 2.3 pg/ml or IFN- ≥ 0.5 pg/ml). The study participants were 63.9% women with mean age of 40.7 years. All participants had detectable IgG; 69.4% displayed high NAbs, and 75.0% had IL-2 ≥ 2.3 pg/ml. IgG correlated positively with IL-2 (ρ = 0.667; p < 0.0001) but negatively correlated with IFN- (ρ = -0.535; p = 0.0008). NAbs were positively associated with IL-2 (ρ = 0.341; p = 0.0416) but negatively associated with IFN- (ρ = -0.740; p < 0.0001). Of the participants, 25 (69.4%) were classified as robust and 11 (30.6%) as non-robust. Robust profiles showed higher IgG, NAbs, and IL-2 levels, whereas non-robust profiles had higher IFN-. Vaccination status did not significantly differentiate groups. In conclusion, in Ivorian healthcare workers, robustness of the post-infection immune response is based on the synergy between NAbs and IL-2. Conversely, high IFN- levels were associated with weaker neutralization, probably influenced by post-infection kinetics. These results suggested that immune monitoring should integrate combined profiles, beyond IgG alone, to identify individuals requiring priority vaccination follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Allergology, Faculty of Medical Sciences, Université Félix Houphouët-Boigny, Abidjan, Côte d'Ivoire.
- Laboratory of Immunology and Hematology, University Hospital of Cocody, Abidjan, Côte d'Ivoire.
- National Blood Transfusion Center (CNTSCI), Abidjan, Côte d'Ivoire.
Zitieren
APA
Goran-Kouacou, A. P. V., Dassé, S. R., Adou, A. H., Yéboah, O. R., Assi, A. U. A., Moussa, N. S., Séri, Y. J., Attoukoula, A. T. E., Oura, B. D. Y., Guessan, K. N., & Siransy, K. L. (2026). Post-covid-19 immune signatures: Antibody and Th1 cytokine profiles among healthcare workers in Côte d’Ivoire. The Egyptian journal of Immunology. https://doi.org/10.55133/eji.330107
Vancouver
Goran-Kouacou APV, Dassé SR, Adou AH, Yéboah OR, Assi AUA, Moussa NS, et al. Post-covid-19 immune signatures: Antibody and Th1 cytokine profiles among healthcare workers in Côte d’Ivoire. The Egyptian journal of Immunology. 2026. doi:10.55133/eji.330107
BibTeX
@article{GoranKouacou2026,
author = {Goran-Kouacou, Amah P V and Dassé, Séry R and Adou, Adjoumanvoulé H and Yéboah, Oppong R and Assi, Aya U A and Moussa, Nangninlyomi S and Séri, Yida J and Attoukoula, Angbonon T E and Oura, Brou D Y and Guessan, Koffi N and Siransy, Kouabla L},
title = {Post-covid-19 immune signatures: Antibody and Th1 cytokine profiles among healthcare workers in Côte d’Ivoire},
journal = {The Egyptian journal of Immunology},
year = {2026},
doi = {10.55133/eji.330107}
}
EUVIMED